To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive
a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles.
Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive
evaluation and ratings from patients.
My treatment philosophy is to deliver personalized care that integrates the latest developments in science, while keeping in mind the individual’s personal goals. I encourage my patients to be active participants in their care and I value the trust they place upon me as their provider.
Postdoctoral Fellow, Vanderbilt University, Department of Medicine, Department of Medicine, Division of Clinical Pharmacology, Nashville, TN, 2014
Fellow, Hematology/Oncology, Vanderbilt University, Department of Medicine, Division of Hematology/Oncology , Nashville, TN, 2012
Residency, Vanderbilt University, Department of Medicine, Division of Hematology/Oncology , Nashville, TN, 2009
MD, University of Minnesota Medical School, Minneapolis, MN, 2007
PhD, Neuroscience, University of Minnesota, Minneapolis, MN, 2005
MS in Science, Zoology and Physiology, Louisiana State University, Baton Rouge, LA, 1999
Hematology, American Board Internal Medicine
Internal Medicine, American Board Internal Medicine
American Heart Association, Early Career Member
American Society of Clinical Oncology, Associate Member
American Society of Hematology, Associate Member
Hemostasis and Thrombosis Research Society, Associate Member
International Society on Thrombosis and Haemostasis, Member
MRA Reviewer since 2014
SWOG/NCI Cancer Research Cooperative Group, Member
Honors & Awards
That's the Way Player of the Month Award: Award for dedication and exceptional service to patient care, January 2018.
Travel Award Recipient, Hemostasis and Thrombosis Research Society, May 2017
Cancer associated thrombosis
Ongoing Clinical Trial Studies
USE OF METFORMIN AS A FETAL HEMOGLOBIN INDUCER IN PATIENTS WITH HEMOGLOBINOPATHIES (FITMET)
(Pl: Vivien Sheehan, MD, PhD). Phizer, Inc. Role: Co-Investigator.
SAMPLE COLLECTION FOR DEVELOPMENT OF A NON-INVASIVE PRENATAL TEST FOR HEMOGLOBINOPATHIES. (Pl: Vivien
Sheehan, MD, PhD). Billion To One. Role: Co-Investigator.
RESVERATROL IN METABOLIC SYNDROME: EFFECT ON PLATELET HYPER-REACTIVITY AND HDL LIPID PEROXIDATION.
(Pl: Iberia R Sosa). American Heart Association. Role: Pl
COMPARISON OF ORAL ANTICOAGULANTS FOR EXTENDED VENOUS THROMBOEMBOLISM (COVET).
(Pl: Thomas Orte!, MD, PhD). Patient Centered Outcomes Research Institute. Role: Site Pl.
551: PILOT STUDY OF SERTRALINE IN TREATMENT OF LOW-RISK MYELODYSPLASTIC SYNDROME.
(Pl: Gustavo Rivero, MD). Golfers Against Cancer. Role: Co-Investigator
R. Sosa, S. Li, J.T. Molony, J. Liu, S. Stryker, AJ Collins. Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database. Supportive Care in Cancer. 2017 Apr 29. [PMID: 28456908]
0. Boutaud, I. R. Sosa, T. Amin, G. Milne, D. Adler, H.S. Hwang, B. Crews, G.L. Milne, B.K. Harris, M.D. Hoeksema,
B.C. Knowllmann, P.E. Lammers, L.J. Marnett, P.P. Massion, J. A. Oates JA. Aspirin inhibits prostaglandin Ez production by lung adenocarcinoma cells by direct and platelet mediated interactions. Cancer Prevention Research. 2016 Nov;9(11):855-865. [PMID: 27554763].
I. Zagol-lkapite, I.R. Sosa, D. Oram, A. Judd, K. Amarnath, D. Stec, J. Oates, 0. Boutaud. Modification of platelet proteins by malondialdehyde: prevention by dicarbonyl scavengers. Journal of Lipid Research. 2015 Nov; 56(11):21960205. [PMID: 26378094].
I.R. Sosa, D. Gailani and A.T. Neff. Development of FXIII inhibitor in a patient with congenital FXIII deficiency receiving interferon and ribavarin therapy for chronic hepatitis C infection. Haemophilia: 2014 Nov;20(6): e429-32. [PMID: 25333572].
I.R. Sosa, P. Ellery, A. Mast, A.T. Neff and D. Gailani. Acquired Factor V deficiency in a patient without evidence of a classical inhibitor. Haemophilia: 2014 Jan; 20(1): e81-3. [PMID: 24118596].
B. Taylor, R.Sosa, W.M. Stone. Bromide Toxicity from Consumption of Dead Sea Salt, American Journal of Medicine. American Journal of Medicine: 2010 Mar;123(3): ell-2. [PMID: 20193810].
R. Sosa and E. Gleason. Activation of mGluRS modulates calcium currents in retinal amacrine cells1 Visual Neuroscience, 21: 807-816, 2004. [PMID:15733336]
R. Sosa, B. Hoffpauir, M. Rankin, R. Bruch and E. Gleason. Metabotropic glutamate receptor 5 and calcium signaling in retinal amacrine cells. Journal of Neurachemistry 81(5): 973-83, 2002. [PMID: 12065609].
R. Sosa, and M. Udden (2017). Critical Care in Obstetrics. In M. Belfort, J. Phelan, G. Saade, M. Foley. Sickle Cell Disease and Pregnancy. (in press)
The following ratings and reviews are based on verified feedback collected from independently administered
patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions.
Patient identities are withheld to ensure confidentiality and privacy.
Learn more about our Patient Experience Ratings.